2,3,5-Triphenyl-2H-tetrazolium chloride Cas:298-96-4 98% Off-white/pale yellow crystalline powder
| Nomoro ea lethathamo | XD90154 |
| Lebitso la Sehlahiswa | 2,3,5-Triphenyl-2H-tetrazolium chloride |
| CAS | 298-96-4 |
| Foromo ea limolek'hule | C19H15N4·Cl |
| Boima ba Molek'hule | 334.80 |
| Lintlha tsa polokelo | 2 ho isa ho 8 °C |
| Khoutu ea Lekhetho e Kopantsoeng | 29339980 |
Tlhaloso ea Sehlahisoa
| Ponahalo | Phofo ea kristale e mosehla e mosehla / e mosehla |
| Assay | Min.98% |
| Melting Point | 235 - 245 Deg C |
| Tahlehelo ka ho Omisa | <3.0% |
| Litaba tsa Metsi | 0.5% Max |
| Masalla a ho Ignition | Max.0.5% |
| Solubility ka EtoH | Feta |
| Ho qhibiliha ha Ethanol | E hlakileng le e felletseng |
Ho batlisisa phello e molemo ea motsoako oa butyrate, Lactobacillus casei, le L-carnitine ka mokhoa oa rat colitis.Likhoto li ne li arotsoe ka lihlopha tse supileng.Lihlopha tse 'nè li ile tsa fumana molomo butyrate, L-carnitine, Lactobacillus casei le motsoako oa mahlahana a mararo bakeng sa matsatsi a 10 a latellanang.Lihlopha tse setseng li ne li kenyelletsa litsamaiso tse mpe le tse ntle le sehlopha sa sham.Macroscopic, litlhahlobo tsa histopathological, le li-biomarker tse kang tumor necrosis factor-alpha (TNF-α) le interlukin-1β (IL-1β), myeloperoxidase (MPO), thiobarbituric acid reactive substances (TBARS), le matla a fokotsehileng a plasma (FRAP) ) li ile tsa khethoa ka har'a colon.Kalafo ea motsoako e bontšitse phello e ntle ea ho fokotsa lefu la ho ruruha ha boko ho bapisoa le ho laola.Liphetoho tse akaretsang tsa ho fokotseha ha TNF-α (114.66 ± 18.26 vs 171.78 ± 9.48 pg / mg protheine, P <0.05), IL-1β (24.9 ± 1.07 vs 33.06 ± 2.16 pg / mg protheine, P2 <0.05.), TBARS. ± 0.03 vs 0.49 ± 0.04 μg/mg protheine, P <0.01), MPO (15.32 ± 0.4 vs 27.24 ± 3.84 U/mg protheine, P <0.05), le bophahamo ba FRAP (23.46 ± 1.3 μmo ± 1.2/7 vs , P <0.05) tšehetsa khetho ea phekolo ea motsoako ha e bapisoa le ho laola.Le hoja li-monotherapies li ne li boetse li atlehile ntlafatsong ea matšoao a lefu la colitis, phekolo e kopantsoeng e ne e le betere ho ntlafatsa matšoao a khatello ea kelello ea oxidative ho akarelletsa le FRAP, TBARS, le MPO. boemo ba kliniki.
